• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
H.C. Wainwright Analyst Reiterates Buy Rating on Ocugen
11:32
Nov5
Ocugen released FY2025 Q3 earnings on November 5 Pre-Market EST, actual revenue USD 1.752 M (forecast USD 440 K), actual EPS USD -0.0699 (forecast USD -0.056)
14:30
Ocugen released FY2025 9 Months Earnings on November 5, Pre-Market EST, with actual revenue of USD 4.606 M and EPS of USD -0.1689
14:30
Ocugen Inc. Reports Clinical Trial Progress and Completes $20 Million Direct Offering
11:30
Oct29
Ocugen to Release FY2025 Q3 Earnings on November 5, Pre-Market EST; Forecast Revenue USD 440 K, EPS USD -0.056
00:47
Oct2
Ocugen Executives to Attend Multiple Conferences to Share Progress in Blindness Gene Therapy
11:31

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.752 M, Net Income -20.05 M, EPS -0.0659

Aug1
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.373 M, Net Income -14.74 M, EPS -0.0504

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.481 M, Net Income -15.35 M, EPS -0.0525

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More